GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Clinical trials for GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS explained in plain language.
Never miss a new study
Get alerted when new GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS trials appear
Sign up with your email to follow new studies for GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug fix period problems in teens with type 1?
Disease control ENROLLING_BY_INVITATIONThis study looks at whether dulaglutide, a drug used for type 2 diabetes, can help regulate menstrual cycles in adolescent girls with type 1 diabetes who have poor blood sugar control. Researchers will give some participants dulaglutide plus insulin, while others get only insulin…
Matched conditions: GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Phase: PHASE1, PHASE2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Popular Weight-Loss drugs may change Pre-Surgery fasting rules
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how GLP-1 receptor agonists (like Ozempic or Wegovy) affect how fast the stomach empties before surgery. These drugs are used for weight loss and diabetes, but they slow stomach emptying, which could raise the risk of food or liquid entering the lungs during a…
Matched conditions: GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Sponsor: Wael Saasouh, MD • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:18 UTC